HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of acquired amegakaryocytic thrombocytopenic purpura with romiplostim.

AuthorsToshio Shigekiyo, Etsuko Sekimoto, Hironobu Shibata, Shuji Ozaki, Hiroyuki Fujinaga, Takanori Hirose
JournalPlatelets (Platelets) Vol. 26 Issue 5 Pg. 504-6 ( 2015) ISSN: 1369-1635 [Electronic] England
PMID24832714 (Publication Type: Case Reports, Letter)
Chemical References
  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim
Topics
  • Bone Marrow Diseases (diagnosis, drug therapy, etiology)
  • Humans
  • Male
  • Middle Aged
  • Platelet Count
  • Purpura, Thrombocytopenic (diagnosis, drug therapy, etiology)
  • Receptors, Fc (therapeutic use)
  • Recombinant Fusion Proteins (therapeutic use)
  • Thrombopoietin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: